These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12624002)

  • 1. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.
    Kuwahara F; Kai H; Tokuda K; Niiyama H; Tahara N; Kusaba K; Takemiya K; Jalalidin A; Koga M; Nagata T; Shibata R; Imaizumi T
    Hypertension; 2003 Mar; 41(3 Pt 2):819-23. PubMed ID: 12624002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?
    Kuwahara F; Kai H; Tokuda K; Takeya M; Takeshita A; Egashira K; Imaizumi T
    Hypertension; 2004 Apr; 43(4):739-45. PubMed ID: 14967845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
    Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
    Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.
    Kuwahara F; Kai H; Tokuda K; Kai M; Takeshita A; Egashira K; Imaizumi T
    Circulation; 2002 Jul; 106(1):130-5. PubMed ID: 12093782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts.
    Tokuda K; Kai H; Kuwahara F; Imaizumi T
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S61-5. PubMed ID: 14871031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis.
    Kai H; Kuwahara F; Tokuda K; Imaizumi T
    Hypertens Res; 2005 Jun; 28(6):483-90. PubMed ID: 16231753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women.
    Mori T; Kai H; Kajimoto H; Koga M; Kudo H; Takayama N; Yasuoka S; Anegawa T; Kai M; Imaizumi T
    Hypertens Res; 2011 Apr; 34(4):496-502. PubMed ID: 21248760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
    Kudo H; Kai H; Kajimoto H; Koga M; Takayama N; Mori T; Ikeda A; Yasuoka S; Anegawa T; Mifune H; Kato S; Hirooka Y; Imaizumi T
    Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II.
    Kai H; Mori T; Tokuda K; Takayama N; Tahara N; Takemiya K; Kudo H; Sugi Y; Fukui D; Yasukawa H; Kuwahara F; Imaizumi T
    Hypertens Res; 2006 Sep; 29(9):711-8. PubMed ID: 17249527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.
    Higashiyama H; Sugai M; Inoue H; Mizuyachi K; Kushida H; Asano S; Kinoshita M
    Int J Exp Pathol; 2007 Feb; 88(1):31-8. PubMed ID: 17244336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Karam H; Heudes D; Hess P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Cardiovasc Res; 1996 Feb; 31(2):287-95. PubMed ID: 8730406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats.
    Nicoletti A; Mandet C; Challah M; Bariéty J; Michel JB
    Cardiovasc Res; 1996 Apr; 31(4):585-95. PubMed ID: 8689650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation.
    Berni R; Savi M; Bocchi L; Delucchi F; Musso E; Chaponnier C; Gabbiani G; Clement S; Stilli D
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1625-32. PubMed ID: 19252091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of postlaminectomy epidural fibrosis with monoclonal antibodies against intercellular adhesion molecule-1 and CD-18.
    Sabuncuoğlu H; Bavbek M; Sabuncuoğlu B; Gadelha E; Köse K; Preul M
    Spine J; 2007; 7(4):459-65. PubMed ID: 17630144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
    Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T; Kato J; Hatakeyama K; Masuyama H; Cao YN; Imamura T; Kitamura K; Asada Y; Eto T
    Cardiovasc Res; 2005 Mar; 65(4):921-9. PubMed ID: 15721873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
    Takayama N; Kai H; Kudo H; Yasuoka S; Mori T; Anegawa T; Koga M; Kajimoto H; Hirooka Y; Imaizumi T
    Hypertens Res; 2011 Mar; 34(3):341-7. PubMed ID: 21124329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes.
    Rizzi E; Castro MM; Ceron CS; Neto-Neves EM; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Int J Cardiol; 2013 Apr; 165(1):165-73. PubMed ID: 21917342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis and hypertensive heart disease.
    Weber KT
    Curr Opin Cardiol; 2000 Jul; 15(4):264-72. PubMed ID: 11139090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.